|
AE89129 |
HP 236 |
131540-59-5 |
C22H30FN3OS2 |
435.6215 |
VIEW DETAILS > |
|
AZ55679 |
Hydrazinecarbothioamide, 2-[(2-nitrophenyl)methylene]- |
6072-63-5 |
C8H8N4O2S |
224.2397 |
VIEW DETAILS > |
|
BD74697 |
Hydrazinecarbothioamide, 2-[(5-chloro-2-hydroxyphenyl)methylene]- |
20234-13-3 |
C8H8ClN3OS |
229.6866 |
VIEW DETAILS > |
|
BE23274 |
Hydrazinecarboxamide, 2-[[4-(dimethylamino)phenyl]methylene]- |
2929-82-0 |
C10H14N4O |
206.2444 |
VIEW DETAILS > |
|
BN54170 |
Hibercell GCN2 inhibitor HC-7366 |
2803470-63-3 |
C20H15ClF2N6O4S |
508.8857 |
VIEW DETAILS > |
|
BO43965 |
HG-7-86-01 |
1258391-14-8 |
C28H21F3N6O2S |
562.5655 |
VIEW DETAILS > |
|
BO43973 |
Hydroxy-PP |
833481-60-0 |
C15H17N5O |
283.3284 |
VIEW DETAILS > |
|
BO48015 |
Hexanedioic acid, heptyl nonyl ester |
86248-24-0 |
C22H42O4 |
370.5665 |
VIEW DETAILS > |
|
BM23425 |
Hyaluronic acid, 2-(2-methyl-1-oxo-2-propen-1-yl)hydrazide degree of substitution 20% |
2708286-23-9 |
|
|
VIEW DETAILS > |
|
BO20336 |
Human PD-L1 inhibitor V |
2815311-61-4 |
C65H104N20O18S |
1485.7095 |
VIEW DETAILS > |